跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 97,609 条关于
“kallikrein-related peptidase 2”
全部
97,609
临床试验
68,182
药物
7,980
机构
1,476
资讯
19,971
去年
Juri Biosciences Secures Global Rights to KLK2-Targeted T-Cell Engager for Metastatic Prostate Cancer in $210M Deal
2年前
Advancements in Neuroplastogens, KRAS G12C Inhibitors, and Other Therapies Highlighted by Recent Deals and Clinical Readouts
去年
Triveni Bio Initiates First-in-Human Trial of TRIV-509 for Atopic Dermatitis, Targeting Novel Kallikrein Pathway
10个月前
Radiopharm Theranostics Receives Ethics Approval for First-in-Human Trial of RAD 402 in Advanced Prostate Cancer
去年
Ampligen Shows Potential in Treating Fatigue in Post-COVID Conditions, AIM ImmunoTech Announces
去年
Rezolute's Oral Plasma Kallikrein Inhibitor RZ-402 Shows Promise in Phase IIa Trial for Diabetic Macular Edema
去年
NTLA-2002 Demonstrates Significant Reduction in Angioedema Attacks via CRISPR-Cas9 Gene Editing
去年
Qu Biologics Completes Enrollment in Phase 2 Trial Testing Novel Immunomodulator for Age-Related Immune Decline
去年
NTLA-2002 Shows Promise as Functional Cure for Hereditary Angioedema in Phase 2 Trial
去年
Rejuvenate Biomed Partners with NIHR Leicester BRC for Phase 2 Trial of Novel COPD-Related Sarcopenia Treatment
第 1 页，共 1998 页
上一页
下一页
